For Healthcare Professionals OnlyPartner Portal
For questions about coronavirus/COVID-19 and using NIOX VERO®, please visit the NIOX VERO Coronavirus/COVID-19 FAQ.
NIOX has been the preferred FeNO device used in global research trials for almost ten years by pharmaceutical companies, clinical research organisations, and government and academic groups. Monitoring FeNO has proved to be a valuable biomarker and is continually included in clinical trial protocols.1-4
Circassia provides the following services for your FeNO research needs:
For any more information regarding clinical research, please contact us at email@example.com.
References: 1. Data on file. Circassia Ltd February 2020. C-NIOX-0004 2. Petsky et al. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016 11:CD011439. 3. Petsky et al. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev. 2016 11:CD011440. 4. NICE guideline [NG80]: Asthma: diagnosis, monitoring and chronic asthma management. 2017